Form 4: Phreesia SVP David Linetsky Reports Correction and RSU Grant in Form 4 Filing

David Linetsky, SVP of Life Sciences at Phreesia, Inc., filed a Form 4 detailing a corrected stock holding and a grant of Restricted Stock Units (RSUs) in lieu of a portion of his cash bonus.

Summary

• David Linetsky, SVP of Life Sciences at Phreesia, Inc., filed a Form 4 with the SEC.
• The filing reports a correction to previously underreported common stock holdings due to a vendor administrative oversight, adjusting the total holdings by 3,413 shares.
• The filing also reports the grant of 6,968 Restricted Stock Units (RSUs) to Linetsky, representing awards received in lieu of 50% of his cash bonus for the fiscal year ending January 31, 2025.
• The RSUs were fully vested as of the grant date of April 4, 2025, and were calculated based on a per share value of $24.31.
• The total common stock beneficially owned following the reported transactions is 225,682 shares directly and 9,260 shares indirectly by spouse.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The correction of a previous error is a good sign of transparency, and the RSU grant indicates continued alignment between the executive and the company's success. However, the initial oversight is a minor concern.

Positives

• The grant of RSUs in lieu of cash bonus aligns Linetsky's interests with the company's performance.
• The correction of previously reported holdings demonstrates transparency and accuracy in reporting.

Negatives

• The need to correct a previous filing indicates a past administrative oversight.

Risks

• Potential for future administrative errors in reporting holdings.
• Fluctuations in the stock price could impact the value of the RSUs.

Future Outlook

Not explicitly stated, but the RSU grant suggests continued employment and alignment with company performance.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

• Form 4 filings are a standard regulatory requirement for publicly traded companies in the United States, ensuring transparency regarding insider transactions.
• Companies like Veeva Systems and Allscripts Healthcare Solutions also have executives who regularly file Form 4s, reflecting similar transactions such as stock option exercises and RSU grants.
• The reporting practices in this Form 4 are consistent with SEC guidelines and industry norms for insider trading disclosures.

Stakeholder Impact

• Shareholders are informed about changes in insider ownership.
• The RSU grant incentivizes the executive to contribute to the company's success, potentially benefiting shareholders.

Key Dates

Keywords

Form 4, Phreesia, Linetsky, RSU, Restricted Stock Units, Stock Options, Beneficial Ownership, Correction